by Paul Nardone | May 21, 2020
During our Quarterly Update call with clients, I received a question about what COVID-19 is revealing regarding IT solutions that engage community resources. I took the question to be about what functionality in those solutions is most pertinent to addressing COVID-19, and answered as such. However, after the call ended, ...
by John Moore | May 06, 2020
As sheltering in place wears on, I keep all in perspective knowing others have it far worse than I. Some have lost loved ones, others their jobs and others are still facing down the COVID-19 virus on a daily basis delivering care and comfort to those that have been infected. ...
by John Moore III | April 15, 2020
During this webinar, Chilmark analysts will update you on the key trends and market events they were following over the last quarter and what they are looking forward to in the next few months. They also present early findings from ongoing research projects and implications for providers, payers, vendors, and ...
by Jody Ranck | April 13, 2020
As the COVID-19 pandemic continues to spread across the US there are emerging patterns for the disease burden coming to light. African-American and Latinx populations are suffering a disproportionate amount of the disease burden and deaths. It is often said that pandemics are a window into society and amplify health ...
by Paul Nardone | April 07, 2020
Healthcare fights a two-front war against COVID-19, yet only one of the two fronts has been the beneficiary of widespread media attention. While healthcare workers (doctors, nurses, hospital staff, etc.) nobly work each day to treat patients and the media closely reports their struggles, healthcare’s community partners also scramble to ...
by Alex Lennox-Miller | April 01, 2020
The COVID-19 crisis is an acid test for the value of telehealth and remote medicine in patient-centered and community care. Our 2018 Telehealth report described the opportunities and regulatory environment telehealth contended in. Now, new exceptions and regulations by CMS, the Office for Civil Rights, and the FDA are easing ...
by John Moore III |
Join Senior Analyst and report author Jody Ranck for a presentation of the key findings from Chilmark Research's latest report, The Promise of AI and ML in Healthcare: Opportunities, Challenges, and Vendor Landscape. In this webinar, Jody discusses trends across applications of artificial intelligence and machine learning in healthcare, including: business ...
by Jody Ranck | March 30, 2020
Pandemics are by definition a global issue and it is in the interest of all nations to pay attention to the global response to the emerging COVID-19 outbreak. This is not a time for myopic views or “America First” at the exclusion of learning lessons in real-time from what is ...
by John Moore | March 25, 2020
I founded Chilmark Research to help move the healthcare industry forward to improving care delivery through the effective use of information technology (IT). A key part of that mission is to educate by providing all stakeholders with objective research and resources. Today, the world is seeing a nearly unprecedented spread ...
by John Moore |
As the #COVID19 pandemic storms across the U.S., a thought I’ve been pondering is: Will there be a measurable difference in ability to respond by those healthcare systems that have aggressively moved forward with adopting a population health management (PHM) strategy and supporting technology coupled with value-based care (VBC) models? ...
by John Moore | March 20, 2020
Several weeks ago we were preparing for HIMSS’20 – something the entire Chilmark Research team attends every year. HIMSS'20 was cancelled. Today, we are completely virtual. Luckily, this is not a drastic leap for us as I started Chilmark Research 13 years ago with a virtual model in mind, using ...
by Brian Murphy | March 16, 2020
New rules from CMS and ONC hold few surprises for devotees of the regulatory process – a niche crowd, admittedly. Both agencies thoroughly communicated and responded to the industry at every step. What’s more, the functional aspects in these requirements are already being done — somewhere in the U.S. healthcare system. ...
by Hannah Ehnle | March 13, 2020
Even with HIMSS'20 canceled, the Chilmark team still wants to share our insights and guidance on the health IT market! In this webinar, each analyst presents an overview of the market trends they are following and what they are most excited about when looking ahead. They also discuss some preliminary ...
by John Moore | March 02, 2020
The population health management (PHM) journey for provider organizations is not paved in gold, nor silver – it’s actually not paved at all – more of a dirt path with a steep climb. It is far from smooth and the ability to show demonstrable return on investment remains elusive. This ...
by Jody Ranck | February 24, 2020
Several years ago we highlighted the analytics work behind the Camden Healthcare Coalition’s hotspotting methodology used to identify super utilizers in the local health system so that appropriate interventions could be provided to decrease unnecessary utilization. The approach was highlighted in a widely read article by Atul Gawande in the ...
by Chilmark Team | February 13, 2020
Once again, the Chilmark team is headed to Orlando for another HIMSS Global Conference and Exhibition. While many focus on the excitement in the exhibit hall and evening networking events, there is also a wealth of wisdom shared in educational sessions throughout the convention center all week. Here are our ...
by Brian Murphy | February 07, 2020
The healthcare exchange status quo got a boost last week in a legal victory for Ciox Health. The release of information vendor challenged HHS guidance that limited the fees it could charge when patients asked it to transmit their data to third parties. The decision frees companies from constraints on ...
by John Moore | February 05, 2020
Or Interop, Privacy and Advancing Care The annual ONC meeting last week brought together stakeholders to discuss policy for health IT and most importantly, interoperability. With new interoperability rules expected in the coming weeks, this was a particularly important meeting with no less than HHS Sec. Azar giving a keynote. ...
by Alex Lennox-Miller | January 30, 2020
Roughly two years after we reviewed the first FDA guidance on Clinical Decision Support (CDS), FDA issued new draft guidance. The FDA was criticized for not basing their first draft regulation criteria on use-case risk. Since then the International Medical Device Regulators Forum (IMDRF), which the FDA chaired, created a ...
by John Moore | January 20, 2020
Last week was the annual pilgrimage to San Francisco to attend the J.P. Morgan (JPM) conference. Actually, I do not attend the JPM conference itself, but several of the satellite events that happen concurrently. Home base is typically the well-orchestrated, albeit slightly hyped, Start-up Health Festival but most of my ...
